Animal Models of Demyelination
Open Access
- 1 July 1996
- journal article
- review article
- Published by Wiley in Brain Pathology
- Vol. 6 (3), 303-311
- https://doi.org/10.1111/j.1750-3639.1996.tb00857.x
Abstract
Demyelination is a pathological feature that is characteristic of many diseases of the central nervous system (CNS) including multiple sclerosis (MS), sub-acute sclerosing panencephalomyelitis (SSPE), metachromatic leukodystrophy and Pelizaeus-Merzbacher disease. While demyelination is a pathological end-point that is common to all of these diseases, the cellular and molecular mechanisms responsible for this pathology are very different. These range from genetic defects that affect lipid metabolism in the leukodystrophies, cytopathic effects of viral infection in SSPE to the action of immunological effector mechanisms in MS and the viral encephalopathies. Irrespective of the initial cause of myelin degradation, many of these disorders are associated with some degree of CNS inflammation, as indicated by the local activation of microglia, recruitment of macrophages or the intrathecal synthesis of immunoglobulin. Many of these phenomena are now being duplicated in animal models, providing not only new insights into the pathogenesis of human demyelinating diseases, but also unexpected interrelationships between the immune response in the CNS and the pathogenesis of diseases such as Alzheimers disease and HIV encephalopathy. Autoimmune mediated models of inflammatory demyelinating CNS disease have proved particularly valuable in this respect as they allow the effects of defined immune effector mechanisms to be studied in the absence of CNS infection.Keywords
This publication has 81 references indexed in Scilit:
- Overexpression of DM20 messenger RNA in two brothers with pelizaeus‐merzbacher diseaseAnnals of Neurology, 1995
- Animal models of human disease Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating diseaseClinical Immunology and Immunopathology, 1995
- Experimental strategies to promote central nervous system remyelination in multiple sclerosis: Insights gained from the Theiler's virus model systemJournal of Neuroscience Research, 1995
- Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein geneNeuron, 1994
- A Single Nucleotide Difference in the Gene for Myelin Proteolipid Protein Defines the Jimpy Mutation in MouseJournal of Neurochemistry, 1987
- An AG→GG transition at a splice site in the myelin proteolipid protein gene in jimpy mice results in the removal of an exonFEBS Letters, 1987
- Effect of the Jimpy Mutation on Expression of Myelin Proteins in Heterozygous and Hemizygous Mouse BrainJournal of Neurochemistry, 1984
- FATTY ACID ABNORMALITY IN ADRENOLEUKODYSTROPHYJournal of Neurochemistry, 1976
- Ueber eine eigenthümliche Form spastischer Lähmung mit Cerebralerscheinungen auf hereditärer Grundlage. (Multiple Sklerose)Archiv Fur Psychiatrie Und Nervenkrankheiten, 1885
- Zur Casuistik anomaler Befunde an Gehirnen von Verbrechern und SelbstmördernArchiv Fur Psychiatrie Und Nervenkrankheiten, 1885